Results 201 to 210 of about 614,691 (404)

Access to Specialized Medical Training in Spain and Determinants of Failure in the National Entrance Examination: Econometric Modeling Study. [PDF]

JMIR Form Res
Diaz-Fernandez M, Llorente-Marron M, Asensi V.   +2 more
europepmc   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Examining Japanese laypeople's nationality preferences for physicians: a nationwide study. [PDF]

Sci Rep
Fujikawa H, Mori H, Nishizaki Y, Yano Y, Naito T.   +4 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Assessing health-related quality of life in adolescence: exploring the validity of the Spanish version of the KIDSCREEN-10. [PDF]

Arch Public Health
Pérez-Albéniz A, Lucas-Molina B, Franco-Torres S, Pérez-Esteban A, Ciulin BA, Díez-Gómez A, Fonseca-Pedrero E.   +6 more
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Flüchtlingsfrage und Staatsbürgerschaft in Ungarn nach dem Ersten Weltkrieg bis 1924

Zeitschrift für Ostmitteleuropa-Forschung, 2021
István Gergely Szűts
doaj   +1 more source

Prevalence and selected predictors of vitamin D deficiency among children and adolescents attending primary health care centers: A cross-sectional record-based study, Qatar. [PDF]

Qatar Med J
Khudadad H, Alnuaimi A, Veettil ST, Zainel AA.   +3 more
europepmc   +1 more source

TREX1, a predator for treating MSI‐H tumors?

Molecular Oncology, EarlyView.
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya, Joséphine Deneft, Marc Van den Eynde   +2 more
wiley   +1 more source

Supply and demand for European accounting research. Evidence from EAA congresses [PDF]

We study the supply and demand for European accounting research, referring to author nationality and the country origin of the data to define research as ‘European’.
Cazavan-Jeny, Anne, Jeanjean, Thomas
core   +1 more source